No Data
No Data
China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders
China Touyun Tech Group (HKG:1332) recorded an increase in attributable loss for 2023 to HK$268.9 million, from HK$198.1 million yuan a year ago, according to the company's annual report posted on the
透雲生物:2023年年報
Touyun Biotech Group Limited's (HKG:1332) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Touyun Biotech Group Limited (HKG:1332) shares have retraced a considerable 28% in the last month, reversing a fair amount of their solid recent performance. For any long-term shareholders, the las
Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year
According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.
TOUYUN BIOTECH: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Touyun Biotech (01332.HK) held a board meeting on March 28 to approve publication of annual results
Gelonghui, March 14, 丨 Touyun Biotech (01332.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend.
No Data